| Product Name | NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag |
|---|---|
| Catalog Number | NBL-242338 |
| Alias/Synonyms | LILRB5/CD85c/LIR-8; CD85C ; LIR-8; LIR8 |
| Appearance | see COA |
| Molecule Weight | Arg18-His456 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | O75023-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242338-100ug | 100ug | Inquire | Inquire | |
| NBL-242338-1mg | 1mg | Inquire | Inquire | |
| NBL-242338-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag
Catalog#:
NBL-242338
Description:
NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag(Cat#NBL-242338) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Arg18-His456.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.9 kDa. Due to glycosylation, the protein migrates to 67-72 kDa based on Bis-Tris PAGE result.
Target Name:
LILRB5/CD85c/LIR-8; CD85C ; LIR-8; LIR8
Target Information:
LILRB5, also known as CD85c andLIR-8, belongs to a family of transmembrane glycoproteins that negatively regulate immune cell activation. Mature human LIR-8 consists of a 435 amino acid (aa) extracellular domain with four Ig-like domains, a 21 aa transmembrane segment, and a 111 aa cytoplasmic domain with two immunoreceptor tyrosine-based inhibitory motifs (ITIM). LILRB5 may act as receptor for class I MHC antigens.
Amino Acid Sequence:
Arg18-His456
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.